Metaplastic breast carcinoma with squamous differentiation: Molecular and clinical analysis of six cases [3]

Breast Journal

Volumn 11, Issue 5, 2005, Pages 367-369

  Kochhar, Ruby ^a   Howard, Eugene M ^a   Umbreit, Jay N ^a   Lau, Stephen K ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; PROTEIN P53; PROTEIN P63; TAXANE DERIVATIVE; UVOMORULIN; VASCULOTROPIN; TUMOR MARKER; VASCULOTROPIN A;

ADULT; BREAST CARCINOMA; CANCER GRADING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG RESPONSE; DRUG SENSITIVITY; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; HUMAN; LETTER; PHARMACOGENETICS; PROGNOSIS; SQUAMOUS CELL METAPLASIA; SURVIVAL RATE; TUMOR VOLUME; BREAST TUMOR; CANCER STAGING; CARCINOMA; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27744461881     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.00031.x     Document Type: Letter

References (20)

1. Rosen PP, Ernsberger D. Low-grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma. Am J Surg Pathol 1987;115:351-58.
2. Huvos AG, Lucas JC, Foote FW. Metaplastic breast carcinoma: rare form of mammary carcinoma. N Y State J Med 1973;73:1078-82.
3. Chao TC, Wang CS, Chen SC, Chen MF. Metaplastic carcinomas of the breast. J Surg Oncol 1999;71:220-25.
4. Bellino R, Arisio R, D'Addato F, et al. Metaplastic breast carcinoma: pathology and clinical outcome. Anticancer Res 2003;23:669-73.
5. Eggers JW, Chesney TM. Squamous cell carcinoma of the breast: a clinicopathological analysis of eight cases and review of the literature. Hum Pathol 1984;15:526-31.
6. Weigel RJ, Ikeda DM, Nowels KW. Primary squamous cell carcinoma of the breast. South Med J 1996;89:511-15.
7. Hill KA, Sommer SS. p53 as a mutagen test in breast cancer. Environ Mol Mutagen 2002;39:216-27.
8. Reis-Filho JS, Milanezi F, Paredes J, et al. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 2003;11:1-8.
9. Wang X, Mori I, Tang W, et al. Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. Mod Pathol 2001;14:1183-86.
10. Han AC, Soler AP, Knudsen KA, Salazar H. Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum Pathol 1999;30:1035-39.
11. Johnson TL, Kini SR. Metaplastic breast carcinoma: a cytohistologic and clinical study of 10 cases. Diagn Cytopathol 1996;14:226-32.
12. Kuo SH, Chen CL, Huang CS, Cheng AL. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer. Anticancer Res 2000;20:2219-22.
13. Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 1999;10:413-19.
14. Zhang CC, Yang JM, Bash-Babula J, et al. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. Cancer Res 1999;59:3663-70.
15. Kandioler-Eckersberger D, Ludwig C, Rudas M, et al. TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients. Clin Cancer Res 2000;6:50-56.
16. Vacca A, Ribatti D, Iurlaro M, et al. Docetaxel versus paclitaxel for antiangiogenesis. J Hematother Stem Cell Res 2002;11:103-18.
17. Oberman HA. Metaplastic carcinoma of the breast: a clinicopathologic study of 29 patients. Am J Surg Pathol 1987;11:918-29.
18. Toikkanen S. Primary squamous cell carcinoma of the breast. Cancer 1981;48:1629-32.
19. Gauden SJ. Primary squamous cell carcinoma of the breast. Aust Radiol 1992;36:253-54.
20. Eusebi V, Lamovec J, Cattani MG, Fedeli F, Millis RR. Acantholytic variant of squamous-cell carcinoma of the breast. Am J Surg Pathol 1996;10:855-61.